Sanghavi, K <br/><br/>
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.  [electronic resource] 

 -  The pharmacogenomics journal  01 2017 
 - 61-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2015.87  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Black or African American--genetics<br/>Aged<br/>Calcineurin Inhibitors--administration & dosage<br/>Canada--epidemiology<br/>Cytochrome P-450 CYP3A--genetics<br/>Drug Dosage Calculations<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Graft Rejection--ethnology<br/>Graft Survival--drug effects<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Metabolic Clearance Rate--genetics<br/>Middle Aged<br/>Models, Genetic<br/>Pharmacogenetics<br/>Pharmacogenomic Testing<br/>Pharmacogenomic Variants<br/>Phenotype<br/>Tacrolimus--administration & dosage<br/>Transplant Recipients<br/>Treatment Outcome<br/>United States--epidemiology<br/>Young Adult